Also, EGCG arrested the G1 phase of the breast cancer cell cycle by lowering the expression of cyclin D, cyclin E, CDK 4, CDK 1, and proliferating cell nuclear antigen (PCNA). This evidence concerns the gene PCNA and breast cancer.